83 related articles for article (PubMed ID: 1802722)
1. Different action of heparin and fucoidan on arterial smooth muscle cell proliferation and thrombospondin and fibronectin metabolism.
Vischer P; Buddecke E
Eur J Cell Biol; 1991 Dec; 56(2):407-14. PubMed ID: 1802722
[TBL] [Abstract][Full Text] [Related]
2. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. I. Comparison with heparin for antiproliferative activity, binding and internalization.
Logeart D; Prigent-Richard S; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):376-84. PubMed ID: 9438134
[TBL] [Abstract][Full Text] [Related]
3. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.
Religa P; Kazi M; Thyberg J; Gaciong Z; Swedenborg J; Hedin U
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):419-26. PubMed ID: 11112459
[TBL] [Abstract][Full Text] [Related]
4. Modulation of extracellular matrix proteins and the influence of fucoidan on cell proliferation of smooth muscle cells.
Vischer P
Biochem Soc Trans; 1990 Oct; 18(5):962-3. PubMed ID: 2083768
[No Abstract] [Full Text] [Related]
5. Protection of transforming growth factor-beta 1 activity by heparin and fucoidan.
McCaffrey TA; Falcone DJ; Vicente D; Du B; Consigli S; Borth W
J Cell Physiol; 1994 Apr; 159(1):51-9. PubMed ID: 7511146
[TBL] [Abstract][Full Text] [Related]
6. Association of thrombospondin of endothelial cells with other matrix proteins and cell attachment sites and migration tracks.
Vischer P; Völker W; Schmidt A; Sinclair N
Eur J Cell Biol; 1988 Oct; 47(1):36-46. PubMed ID: 3229419
[TBL] [Abstract][Full Text] [Related]
7. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to fibronectin.
Liu JM; Bignon J; Haroun-Bouhedja F; Bittoun P; Vassy J; Fermandjian S; Wdzieczak-Bakala J; Boisson-Vidal C
Anticancer Res; 2005; 25(3B):2129-33. PubMed ID: 16158954
[TBL] [Abstract][Full Text] [Related]
9. The effect of heparin on fibronectin and thrombospondin synthesis by human smooth muscle cells.
Lyons-Giordano B; Conaway H; Kefalides NA
Biochem Biophys Res Commun; 1987 Nov; 148(3):1264-9. PubMed ID: 3689394
[TBL] [Abstract][Full Text] [Related]
10. The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells.
Patel MK; Mulloy B; Gallagher KL; O'Brien L; Hughes AD
Thromb Haemost; 2002 Jan; 87(1):149-54. PubMed ID: 11848445
[TBL] [Abstract][Full Text] [Related]
11. Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect.
Logeart D; Prigent-Richard S; Boisson-Vidal C; Chaubet F; Durand P; Jozefonvicz J; Letourneur D
Eur J Cell Biol; 1997 Dec; 74(4):385-90. PubMed ID: 9438135
[TBL] [Abstract][Full Text] [Related]
12. Sodium spirulan as a potent inhibitor of arterial smooth muscle cell proliferation in vitro.
Kaji T; Okabe M; Shimada S; Yamamoto C; Fujiwara Y; Lee JB; Hayashi T
Life Sci; 2004 Mar; 74(19):2431-9. PubMed ID: 14998720
[TBL] [Abstract][Full Text] [Related]
13. Characterization of rat aortic smooth muscle cells resistant to the antiproliferative activity of heparin following long-term heparin treatment.
Bârzu T; Herbert JM; Desmoulière A; Carayon P; Pascal M
J Cell Physiol; 1994 Aug; 160(2):239-48. PubMed ID: 8040184
[TBL] [Abstract][Full Text] [Related]
14. Modulation of vascular human endothelial and rat smooth muscle cell growth by a fucosylated chondroitin sulfate from echinoderm.
Tapon-Bretaudière J; Drouet B; Matou S; Mourão PA; Bros A; Letourneur D; Fischer AM
Thromb Haemost; 2000 Aug; 84(2):332-7. PubMed ID: 10959709
[TBL] [Abstract][Full Text] [Related]
15. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin.
Vogel T; Guo NH; Krutzsch HC; Blake DA; Hartman J; Mendelovitz S; Panet A; Roberts DD
J Cell Biochem; 1993 Sep; 53(1):74-84. PubMed ID: 8227183
[TBL] [Abstract][Full Text] [Related]
16. Heparin binding, internalization, and metabolism in vascular smooth muscle cells: I. Upregulation of heparin binding correlates with antiproliferative activity.
Letourneur D; Caleb BL; Castellot JJ
J Cell Physiol; 1995 Dec; 165(3):676-86. PubMed ID: 7593248
[TBL] [Abstract][Full Text] [Related]
17. [Sulfated polysaccharides as inhibitors of receptor activity of P-selectin and P-selectin-dependent inflammation].
Semenov AV; Mazurov AV; Preobrazhenskaia ME; Ushakova NA; Mikhaĭlov VI; Berman AE; Usov AI; Nifant'ev NE; Bovin NV
Vopr Med Khim; 1998; 44(2):135-44. PubMed ID: 9634715
[TBL] [Abstract][Full Text] [Related]
18. Effect of heparin-like compounds on the in vitro proliferation and protein synthesis of various cell types.
Tiozzo R; Cingi MR; Pietrangelo A; Albertazzi L; Calandra S; Milani MR
Arzneimittelforschung; 1989 Jan; 39(1):15-20. PubMed ID: 2719740
[TBL] [Abstract][Full Text] [Related]
19. Isolation of vascular smooth muscle cell cultures with altered responsiveness to the antiproliferative effect of heparin.
Caleb BL; Hardenbrook M; Cherington V; Castellot JJ
J Cell Physiol; 1996 May; 167(2):185-95. PubMed ID: 8613458
[TBL] [Abstract][Full Text] [Related]
20. Entry and distribution of fluorescent antiproliferative heparin derivatives into rat vascular smooth muscle cells: comparison between heparin-sensitive and heparin-resistant cultures.
Bârzu T; Pascal M; Maman M; Roque C; Lafont F; Rousselet A
J Cell Physiol; 1996 Apr; 167(1):8-21. PubMed ID: 8698843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
